YTD, How Many New Highs Are Made By GoodRx Holdings Inc. (GDRX)?

The stock of GoodRx Holdings Inc. (NASDAQ:GDRX) decreased by -$0.13 on Tuesday to finish at $7.38, down -1.73 percent. The last five days have seen an average of 2,649,460 shares of common stock traded. 19 times new highs were reached in the current year, with a gain of $2.72. The average number of shares traded over the last 20 days was 3,265,160, while the average volume over the last 50 days totaled 2,072,768.

GDRX stock dropped -1.86% since last month. On 07/25/23, the company’s shares reached a one-month low of $6.45. The stock touched a high of $9.37 on 07/31/23, after rallying from a low of $3.82 in 52 weeks. The price of GDRX stock has risen by 58.37% or $2.72 this year, reaching a new high 19 times. Still, the stock price is down -21.24% from the 52-week high.

Valuation Metrics

GoodRx Holdings Inc. (GDRX) has a trailing price-to-earnings (P/E) ratio of 263.57. Beta for the stock is 1.11. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.10, the price-to-book (PB) ratio of 3.40, and the price-to-cash flow ratio of 43.95.

Financial Health

For the three months ended June 29, GoodRx Holdings Inc.’s quick ratio was 11.10, while its current ratio was 11.10, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.73, and the total debt to equity ratio is 0.73. As far as profitability goes, gross margin for the trailing twelve months is 90.90% percent. GoodRx Holdings Inc.’s EBITDA margin for the year ended June 29 was 12.35%, whereas its operating margin stood at 1.90% for the same period. Based on annual data, it had gross profit of $701.48 million and revenue of $766.55 million.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. GDRX’s return on assets (ROA) during the last 12 months has been 0.70%. There was a -0.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 1.40%.

Earnings Surprise

According to GoodRx Holdings Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $189.68 million, while revenues fell by -1.12% to $183.99 million. It was predicted that GoodRx Holdings Inc.’s quarterly earnings would be $0.07, but it ended up being $0.06, beating the consensus by 16.70%. EBITDA was $35.25 million for the quarter. At the end of GoodRx Holdings Inc.’s most recent quarter ended June 29, its liabilities totaled 796.73 million, while its total debt was $714.37 million. Equity owned by shareholders amounts to $397.85 million.

Technical Picture

Here’s a quick look at GoodRx Holdings Inc.’s (GDRX) price momentum from a technical perspective. As of 15 August, the RSI 9-day stood at 43.13%, suggesting the stock is Neutral, with a 72.83% historical volatility rate.

The stochastic %K and %D were 37.65% and 46.84% respectively, while the average true range (ATR) was 0.64. Based on the 14-day stochastic reading of 28.67%, the RSI (14) reading is 48.88%. On the 9-day MACD Oscillator, the stock is at -0.64, and the 14-day reading is at -0.54.

Analyst Ratings

In its most recent analyst report, DA Davidson raised its rating on GoodRx Holdings Inc. (NASDAQ: GDRX) to a Buy. Prior to this, analysts firm rated the stock as a Neutral. Analysts have assigned GoodRx Holdings Inc. (GDRX) an Overweight rating. GDRX is a stock that is recommended for selling by 0 brokerage firms, while 14 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 6 others recommend it as a buy.

What is GDRX’s price target for the next 12 months?

The current consensus forecast for the stock is between $6.00 and $12.00, with a median target price of $8.00. In analyzing these forecasts, the average price target given by analysts for GoodRx Holdings Inc. (GDRX) is $8.39.

Most Popular

Related Posts